| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.BPG.2004.06.021 |
| P698 | PubMed publication ID | 15561640 |
| P50 | author | Helena Cortez-Pinto | Q43042720 |
| P2093 | author name string | Maria Ermelinda Camilo | |
| P433 | issue | 6 | |
| P921 | main subject | non-alcoholic steatohepatitis | Q28692677 |
| non-alcoholic fatty liver | Q66299798 | ||
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| steatohepatitis | Q2335423 | ||
| P304 | page(s) | 1089-1104 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Best Practice and Research: Clinical Gastroenterology | Q15754316 |
| P1476 | title | Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course | |
| P478 | volume | 18 |
| Q36172470 | A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease |
| Q42768338 | A hospital-based therapeutic lifestyle program for women with metabolic syndrome |
| Q36028519 | A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease |
| Q37285045 | Aristolochia manshuriensis Kom ethyl acetate extract protects against high-fat diet-induced non-alcoholic steatohepatitis by regulating kinase phosphorylation in mouse |
| Q37596187 | Clinical approaches to non-alcoholic fatty liver disease |
| Q51173989 | Erythrocyte antioxidant defenses as a potential biomarker of liver mitochondrial status in different oxidative conditions. |
| Q47103055 | FXR controls CHOP expression in steatohepatitis |
| Q40707205 | Fatty liver score and 15-year incidence of type 2 diabetes |
| Q41848100 | Hepatic lipid metabolism changes in short- and long-term prehepatic portal hypertensive rats |
| Q46539139 | Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus |
| Q36452544 | Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome |
| Q33575324 | Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey |
| Q35753377 | Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA. |
| Q28082686 | Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease |
| Q36014480 | Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease |
| Q36305927 | Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones |
| Q89474421 | Role of Renin-Angiotensin-converting Enzyme Level and ACE Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease |
| Q34063152 | Skeletal muscle and organ masses differ in overweight adults with type 2 diabetes |
| Q42591676 | Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. |
| Q58147152 | The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis |
| Q34577862 | The effect of citrus flavonoids on the redox state of alimentary-induced fatty liver in rats |
| Q50957805 | Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats. |
Search more.